Report an error
Spotted something inaccurate in “GLP-1 Weight-Loss Drugs Linked to Emerging Eating Disorder Risk Signals”? Tell us what’s wrong and we’ll check it against the original source.
This form is for factual corrections. We read every report but cannot reply individually.